The current study that comes up as having a follow-up CD4 count above 100 cells/μL compared to ≤100 cells/μL was preventing repeated diagnosing of OI recurrence and this is in agreement with other studies [18–22]. The gene discussed is CD4; the disease is osteogenesis imperfecta.